Advisory · Ophthalmology

Gene therapy and sustained delivery are the premium deal drivers.

Ambrosia provides senior-led advisory for ophthalmology licensing, M&A, and strategic partnerships — backed by a proprietary database of 75 verified ophthalmology transactions.

Deal Landscape

What ophthalmology transactions actually look like.

Verified Transactions
75
Median Upfront
$52M
Key Structure Insight
Sustained delivery platforms command platform-level economics in ophthalmology

Related Insights

Research relevant to ophthalmology.

Discuss your ophthalmology transaction.

We’ll meet you at peer level — anywhere in the world.

Issa Kildani

Managing Partner

info@ambrosiaventures.co